Quick Dispatch:
Your glp-1 and parkinson's Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease | Journal of Biomedical Science orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp-1 and parkinson's Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease | Journal of Biomedical Science ships.
Need Help?
Questions about glp-1 and parkinson's Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease | Journal of Biomedical Science, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1 and parkinson's Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease | Journal of Biomedical Science in your area.
Schematic diagram of the underlying mechanisms of EcN‐GLP‐1 in
26.85
GLP-1 drug may help with Parkinson's disease, study reports
25.77
Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases | CNS Drugs
29.91
The Emerging Role of GLP-1 RAs in Parkinson's Disease
25.93
Are we measuring the wrong primary outcome for GLP-1 drugs for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep
29.37
Beyond insulin: The Intriguing role of GLP-1 in Parkinson's disease
29.61
GLP-1 Receptor Agonists for Parkinson's Disease: Promise or Mirage?
25.85
